Literature DB >> 8778901

Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.

D Naber1, P Sand, B Heigl.   

Abstract

Corticosteroids often induce a variety of psychiatric symptoms, such as alterations of mood, neuropsychological deficits and even psychotic states. To date, only a few studies have specifically addressed behaviour as well as cognitive functioning in patients under steroid treatment. Fifty ophthalmologic patients participated in this prospective study. They received methylprednisolone or fluocortolone at doses of 119 +/- 41 mg/day in the beginning and 75 +/- 22 mg after 8 days of treatment. Psychopathology and neuropsychological functioning were examined before and after steroid therapy, mood was self-rated on days 0, 3, 5 and 8. No marked psychopathological abnormalities such as psychosis, dementia or delirious states were observed. However, a significant proportion of patients suffered from an organic mood disorder, 26-34% experienced a hypomanic syndrome, 10-12% a depressive syndrome. Most neuropsychological tests did not reveal significant effects of steroid treatment. Performance of Word Fluency and Trail Making A improved, while the Auditory-Verbal-Learning and the Digit-Symbol showed a worsening. Psychopathological and neuropsychological effects were not significantly correlated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778901     DOI: 10.1016/0306-4530(95)00031-3

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  36 in total

1.  And Tell Yourself, "This is not Me, it's the Drug": Coping with the Psychological Impact of Corticosteroid Treatments in Hematology - Further Results from a Pilot Study.

Authors:  Pam McGrath; Mary Anne Patton; Michael Leahy
Journal:  Patient       Date:  2009-03-01       Impact factor: 3.883

Review 2.  [Effects of high-dose cortisone therapy on cognition].

Authors:  I Uttner; H Tumani
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 3.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 4.  Corticosteroids and Cognition: A Meta-Analysis.

Authors:  Catherine E Prado; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2019-05-26       Impact factor: 7.444

5.  New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study.

Authors:  Katsuji Nishimura; Masako Omori; Eri Sato; Yasuhiro Katsumata; Takahisa Gono; Yasushi Kawaguchi; Masayoshi Harigai; Hisashi Yamanaka; Jun Ishigooka
Journal:  J Neurol       Date:  2014-08-21       Impact factor: 4.849

Review 6.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 7.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 8.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

9.  Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease.

Authors:  Anu E Castaneda; Annamari Tuulio-Henriksson; Eeva T Aronen; Mauri Marttunen; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

10.  A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders.

Authors:  Alan B Frol; Aracely Vasquez; Yonatan Getahun; Maria Pacheco; David A Khan; E Sherwood Brown
Journal:  Allergy Asthma Proc       Date:  2013 Mar-Apr       Impact factor: 2.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.